Nanomedicine News

RSS

NANOBIOTIX Announces Development Plan for CE Marking of NBTXR3

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today its development plan for the CE marking of NBTXR3, the first product from the NanoXray pipeline.

From Nanobiotix 11 Feb 2014

Aarhus University Professor Gets ERC Grant to Develop Tiny Biodegradable Medicine Factories

The development of a new method to build tiny degradable 'medicine factories' inside the body is boosted with a 2 million euro ERC Consolidator Grant. A factory built of gel does not sound very durable. But th...

10 Feb 2014

Sustainable Healthcare with Nanotechnologies and Advanced Materials

According to the Transparency Market Research Nanomedicine Market alone is expected to reach over EUR 120 billion globally in 2019.

10 Feb 2014

Multifunctional Nanoparticle Enables MRI to Pinpoint Blood Vessel Plaques

A team of researchers, led by scientists at Case Western Reserve University, has developed a multifunctional nanoparticle that enables magnetic resonance imaging (MRI) to pinpoint blood vessel plaques caused by atherosclerosis. The technology is a step toward creating a non-invasive method of identifying plaques vulnerable to rupture–the cause of heart attack and stroke—in time for treatment.

7 Feb 2014

Graphene Oxide Nanosheets Incorporated Into Polymer Thin Films for Electronically Controlled Drugs

Potential side effects of many of today's therapeutic drugs can be downright frightening - just listen carefully to a drug commercial on TV.

6 Feb 2014

NanoViricides and Viroclinics Biosciences Ink Confidential Disclosure Agreement

NanoViricides, Inc. (the “Company”) reported today that it has signed a “confidential disclosure agreement” (“CDA”) with Viroclinics Biosciences, BV (“Viroclinics”), a spinoff of the Department of Viroscience at the Erasmus Medical Centre (“Erasmus”) in Rotterdam, the Netherlands.

From NanoViricides, Inc 5 Feb 2014

Scientists Design Endothelialized Microfluidic Device for Testing Nanomedicine

Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease. Scientists have engineered a microchip coated with blood vessel cells to learn more about the conditions under which nanoparticles accumulate in the plaque-filled arteries of patients with atherosclerosis, the underlying cause of myocardial infarction and stroke.

From Georgia Institute of Technology 5 Feb 2014

Caltech Researchers Use High-Resolution Electron Microscopy to Study HIV Infection in the Gut

The human intestinal tract, or gut, is best known for its role in digestion. But this collection of organs also plays a prominent role in the immune system. In fact, it is one of the first parts of the body that is attacked in the early stages of an HIV infection. Knowing how the virus infects cells and accumulates in this area is critical to developing new therapies for the over 33 million people worldwide living with HIV.

31 Jan 2014

NanoViricides New R&D Lab and cGMP Clinical Production Facility in Shelton Nearing Completion

NanoViricides, Inc. (the "Company") reported today that construction of the modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, is nearing completion on schedule. The Company reports that the R&D lab section of the facility is nearing completion, slightly ahead of schedule. In addition, construction of the cGMP Clean Room Production Suite is expected to be completed in March, 2014, on schedule, and shortly thereafter, the project will enter facility testing and validation phase.

From NanoViricides, Inc 28 Jan 2014

Nanodiamond-Silk Structures Help Study Drug-Cell Reaction

Silk and diamonds aren't just for ties and jewelry anymore. They're ingredients for a new kind of tiny glowing particle that could provide doctors and researchers with a novel technique for biological imaging and drug delivery.

28 Jan 2014